Tag: genomics
-

Moderna Gains $483M for Covid-19 Vaccine
A government preparedness agency awarded biotechnology company Moderna Inc. $483 million to advance its Covid-19 vaccine through clinical trials.
-

Covid-19 Antibody Therapy Prepares for Trial
A biotechnology company producing synthetic antibodies in cattle, without human blood, to treat Covid-19 infections is advancing the therapy toward a clinical trial.
-

Analysis Shows Covid-19 Largely Contained in Iceland
Aggressive early testing combined with contact tracing and self-isolation in Iceland appears to be slowing the spread of Covid-19 infections, according to a genetic analysis.
-

Covid-19 Saliva Sample Collection Cleared by FDA
A Covid-19 test procedure using saliva samples rather than specimens from the nose and throat received emergency clearance from the Food and Drug Administration.
-

Univ. Lab to Offer Large-Scale Covid-19 Testing
A University of Maryland lab will seek FDA authorization for its plan to provide high-volume detection testing for Covid-19 infections among state citizens.
-

Five Covid-19 Vaccines in Clinical Trials
A review of vaccines for preventing Covid-19 infections shows five of those projects are in early-stage clinical trials, with 18 more in preclinical stage.
-

Covid-19 Vaccine in Development, Trial Planned
A biotechnology company specializing in infectious diseases is developing a vaccine to protect against Covid-19 infections, with a clinical trial to start next month.
-

Biotechs Explore Cell Therapy for Covid-19 Antibodies
Two biotechnology companies are researching use of a non-viral gene therapy to deliver synthetic antibodies for treating Covid-19 infections.
-

Sanofi, Biotech Partner on RNA Covid-19 Vaccine
Drug maker Sanofi and biotechnology company Translate Bio are creating a new vaccine to protect against the virus causing Covid-19 infections
-

Engineered Blood Cells Created for Cancer Therapies
An academic lab and spin-off company are developing engineered white blood cells with added cancer-killing proteins to attack solid tumor cancers.